As per a US research, it has been revealed that health experts have underestimated the infection severity of bird flu. The study, which has been published in the Journal Nature, has unveiled that the World Health Organization
(WHO) targeted only death cases and forget to stress the mild infection cases.
There is no doubt that in maximum cases bird flu has no escape but death and this is the reason that people have got scared of birds. They feel that bird flu is untreatable and leads to death. However, the WHO figures have intentionally inflated the death numbers.
Bird flu infection cases are double than the deaths taking place in different countries due to it. Lead researcher microbiologist Taia Wang of the Mount Sinai School of Medicine in New York, was of the view that they have assessed more than 600 cases.
The assessment has made them to reach at the conclusion that the WHO has forgotten to account for a majority of infections. It would not be wrong to say that they have targeted severe bird flu cases, who were admitted in hospital taking last few breadths.
It is one of the vast studies ever being conducted on bird flu, said Wang. He further affirmed that they collected virus antibodies samples from 12,677 Asians, Africans and Europeans and to do that they have assessed 27 studies from 1997 to 2009.
After assessing all the studies, the study researchers have reached at a conclusion that the survival rate of bird flu cases is 1.2%, which means that millions of people across the world are able to survive the bird flu infection.
Wang said that their main aim is to pass on the message that bird flu infection cases are quiet more than being reflected. Therefore, all possible preventive measure should be adopted to remain safe from the infection.
- Postage Prices will Decrease from Sunday; USPS not too Happy About It
- Marriott and Starwood Hotels & Resorts Worldwide Inc Shareholders Approve to $14.41 Sales Deal
- UK plan to impose additional tax on sugary drinks
- Obesity during pregnancy may increase risk of very ‘large babies’
- Dropping Sales at Gap’s Key Brands hurt the Company’s Shares